RTTNews | Nov 4, 2021 09:14AM EDT

09:14 Thursday, November 4, 2021 (RTTNews) - Sangamo Therapeutics Q3 Attributable Loss $47.7 Mln Or $0.33/shr Vs. Loss $1.6 Mln Or $0.01/shr Prior Year

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved